3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
55
Unknown
26
Recruiting
17
Active not recruiting
11
Withdrawn
6
Not yet recruiting
4
Terminated
2
Enrolling by invitation
1
Sponsor Class
OTHER
2
INDUSTRY
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
723
Neoplasms
461
Prostatic Neoplasms
398
Carcinoma, Non-Small-Cell Lung
388
Lung Neoplasms
311
Leukemia, Myeloid, Acute
301
Multiple Myeloma
270
Colorectal Neoplasms
243
Neoplasm Metastasis
240
Pancreatic Neoplasms
238
Leukemia
235
Melanoma
217
Lymphoma
213
Precursor Cell Lymphoblastic Leukemia-Lymphoma
204
Brain Neoplasms
195
Recurrence
178
Head and Neck Neoplasms
177
Lymphoma, Non-Hodgkin
174
Myelodysplastic Syndromes
168
Leukemia, Lymphocytic, Chronic, B-Cell
168
Ovarian Neoplasms
160
Carcinoma, Hepatocellular
154
Glioblastoma
149
Carcinoma, Renal Cell
137
Rectal Neoplasms
134
Colonic Neoplasms
129
Lymphoma, Large B-Cell, Diffuse
125
Lymphoma, Follicular
125
Hodgkin Disease
116
Squamous Cell Carcinoma of Head and Neck
109
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
OTHER
×
Breast Cancer Female
×
Clear all
NCT06660030
2025-12-10
TAM
University of Pennsylvania
Terminated
10 enrolled
NCT03131011
2019-06-13
SPOT
CancerCare Manitoba
Phase NA
Terminated
7 enrolled